as 10-28-2025 2:05am EST
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 3.8M | IPO Year: | N/A |
| Target Price: | $287.50 | AVG Volume (30 days): | 64.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -68.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.65 - $84.40 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AEMD Breaking Stock News: Dive into AEMD Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
7 days ago
Zacks Small Cap Research
18 days ago
PR Newswire
21 days ago
TipRanks
2 months ago
PR Newswire
4 months ago
PR Newswire
4 months ago
GlobeNewswire
4 months ago
Zacks Small Cap Research
5 months ago
The information presented on this page, "AEMD Aethlon Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.